Standout Papers

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis 2006 2026 2012 2019 2.4k
  1. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis (2006)
    Chris H. Polman, Paul O’Connor et al. New England Journal of Medicine
  2. Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis (2006)
    Richard A. Rudick, William H. Stuart et al. New England Journal of Medicine

Immediate Impact

17 from Science/Nature 87 standout
Sub-graph 1 of 16

Citing Papers

CAR T therapy beyond cancer: the evolution of a living drug
2023 StandoutNature
Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma
2021 StandoutScience
12 intermediate papers

Works of Frances Lynn being referenced

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
2006 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Frances Lynn 3556 1839 1109 1153 18 4.6k
Gavin Giovannoni 3311 1393 1033 1114 17 4.4k
A Wajgt 2476 1236 857 807 35 3.3k
Gavin Giovannoni 2955 1194 928 1049 62 3.6k
Daniel Wynn 2642 990 765 1117 49 3.5k
Brian Weinshenker 4988 735 924 1863 15 5.8k
Katherine Miszkiel 2963 929 664 1301 47 4.3k
K. P. Johnson 2434 642 1036 1165 40 3.6k
Alfred Sandrock 5213 2914 1537 2088 59 8.2k
J. S. Wolinsky 2756 603 747 1324 37 3.3k
Martin Toal 1837 960 676 582 9 2.5k

All Works

Loading papers...

Rankless by CCL
2026